Additionally, the upregulation of PD-L1 expression was reversed by specific HIF-1α inhibitor, which supports the hypothesis that EVs derived from intermittent hypoxic lung cancer cells upregulate PD-L1 in macrophages via HIF-1α (Fig. 5). This evidence concerns the gene HIF1A and lung cancer.